
Tuesday, September 24, 2024 5:00:11 PM
Recent ELYM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2025 09:15:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2025 09:15:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2025 01:08:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2024 09:15:03 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/25/2024 05:15:09 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 02:29:34 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/12/2024 09:51:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 11:08:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 08:15:00 PM
- Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. • GlobeNewswire Inc. • 10/02/2024 01:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/21/2024 01:53:19 AM
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit • GlobeNewswire Inc. • 09/11/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 09:21:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:47:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2024 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 11:07:00 AM
- Eliem Therapeutics Announces Additions to its Leadership Team • GlobeNewswire Inc. • 08/26/2024 11:00:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/16/2024 08:23:26 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/14/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 10:10:47 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 10:06:54 AM
- Eliem Therapeutics Reports Second Quarter Financial Results • GlobeNewswire Inc. • 08/14/2024 10:05:00 AM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM